Patent · US Active

Muscarinic agonists

US9670209B2 · kind B2 · utility

0Cited by

3References

20Claims

0Family size

Assignees

ACADIA Pharmaceuticals Inc. · US
Allergan, Inc. · US

Inventors

Ethan S. Burstein · San Diego, US
Jorgen Eskildsen · Copenhagen, DK
Roger Olsson · Bunkeflostrand, SE

Key dates

Filing date	Mar 14, 2014
Grant date	Jun 6, 2017
Priority date	—
Expiry date	Mar 14, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D451/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula (I) and methods are provided for the treatment of disease or conditions in which modification of cholinergic, especially muscarinic receptor activity, has a beneficial effect.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.